Ismail Industries Limited operates in the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ismail Industries Limited with three other
bakery and confectionary companies in Asia:
GlaxoSmithKline Consumer Healthcare Limited
sales of 39.86 billion Indian Rupees [US$623.88 million]
of which 100%
Nakamuraya Co., Ltd.
(41.90 billion Japanese Yen [US$376.69 million]
of which 71%
was Confectionery Business), and
Imuraya Group Company Limited
based in Japan
(42.00 billion Japanese Yen [US$377.56 million]
of which 88%
was Distribution Business).
Ismail Industries Limited reported sales of 19.60 billion Pakistan Rupees (US$176.44 million)
June of 2017.
increase of 15.3%
versus 2016, when the company's sales were 17.01 billion Pakistan Rupees.
Sales at Ismail Industries Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 111%).